BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36576122)

  • 21. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies.
    Abdel-Mohsen HT; El Kerdawy AM; Omar MA; Berrino E; Abdelsamie AS; El Diwani HI; Supuran CT
    Bioorg Med Chem; 2020 Mar; 28(5):115329. PubMed ID: 32007388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors.
    Havránková E; Garaj V; Mascaretti Š; Angeli A; Soldánová Z; Kemka M; Motyčka J; Brázdová M; Csöllei J; Jampílek J; Supuran CT
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5168-74. PubMed ID: 23867389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal.
    Mishra CB; Kumari S; Angeli A; Bua S; Buonanno M; Monti SM; Tiwari M; Supuran CT
    Eur J Med Chem; 2018 Aug; 156():430-443. PubMed ID: 30015076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of new series of thiazol-(2(3H)-ylideneamino)benzenesulfonamide derivatives as carbonic anhydrase inhibitors.
    Berber N; Arslan M; Vural F; Ergun A; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2020 Dec; 34(12):e22596. PubMed ID: 32762006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors.
    Moi D; Nocentini A; Deplano A; Osman SM; AlOthman ZA; Piras V; Balboni G; Supuran CT; Onnis V
    Bioorg Chem; 2020 May; 98():103728. PubMed ID: 32182519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies.
    Abo-Ashour MF; Eldehna WM; Nocentini A; Ibrahim HS; Bua S; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2018 Sep; 157():28-36. PubMed ID: 30071407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties.
    Angeli A; Kartsev V; Petrou A; Pinteala M; Brovarets V; Slyvchuk S; Pilyo S; Geronikaki A; Supuran CT
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.
    Kumar R; Sharma V; Bua S; Supuran CT; Sharma PK
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1187-1194. PubMed ID: 28891338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes.
    Türkeş C; Demir Y; Beydemir Ş
    J Biomol Struct Dyn; 2021 Mar; 39(5):1672-1680. PubMed ID: 32107977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facile synthesis and characterization of novel pyrazole-sulfonamides and their inhibition effects on human carbonic anhydrase isoenzymes.
    Balseven H; Mustafa İşgör M; Mert S; Alım Z; Beydemir S; Ok S; Kasımoğulları R
    Bioorg Med Chem; 2013 Jan; 21(1):21-7. PubMed ID: 23218470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, biological evaluation and docking analysis of pyrrolidine-benzenesulfonamides as carbonic anhydrase or acetylcholinesterase inhibitors and antimicrobial agents.
    Poyraz S; Döndaş HA; Yamali C; Belveren S; Demir Y; Aydınoglu S; Döndaş NY; Taskin-Tok T; Taş S; Ülger M; Sansano JM
    J Biomol Struct Dyn; 2024 Apr; 42(7):3441-3458. PubMed ID: 37232497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted furan sulfonamides as carbonic anhydrase inhibitors: Synthesis, biological and in silico studies.
    Angeli A; Kartsev V; Petrou A; Lichitsky B; Komogortsev A; Geronikaki A; Supuran CT
    Bioorg Chem; 2023 Sep; 138():106621. PubMed ID: 37257407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and carbonic anhydrase inhibition activity of benzenesulfonamide-linked novel pyrazoline derivatives.
    Abdel-Aziz AA; El-Azab AS; Bua S; Nocentini A; Abu El-Enin MA; Alanazi MM; AlSaif NA; Hefnawy MM; Supuran CT
    Bioorg Chem; 2019 Jun; 87():425-431. PubMed ID: 30921744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds.
    Petrou A; Geronikaki A; Terzi E; Guler OO; Tuccinardi T; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1306-11. PubMed ID: 26745009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies.
    Alım Z; Köksal Z; Karaman M
    Pharmacol Rep; 2020 Dec; 72(6):1738-1748. PubMed ID: 32748253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.